ArticleDrugs - real world outcomes2025

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with Natalizumab.

Karen Blitz-Shabbir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.